Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: AM, Arch Biopartners, Aslan, Atyr, Basilea, Cerecor, Codagenix, Creative Medical Technology, Dalcor, Dr. Reddy’s, Edesa, Immutep, Kintor, Mesoblast, Neurorx, Quantum Leap Healthcare, Relief, Russian Direct Investment Fund, Sanbio, Serum Institute of India, Windtree.